Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Remifentanil IV PCA for Ablation of Idiopathic Ventricular Tachycardia

NCT01901575 is registered in ClinicalTrials.gov with NYU Langone Health as lead sponsor.

NCT NCT01901575
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01901575 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Remifentanil IV PCA for Ablation of Idiopathic Ventricular Tachycardia
Lead sponsor
NYU Langone Health
Phase
Phase 4
Overall status
Completed
Start date
July 31, 2011
Completion date
April 30, 2013
Enrollment
16 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

tachycardia, ventricular